Northland Securities Downgrades NxStage Medical (NXTM) to Market Perform

Article Stock Quotes (1) Comments (0)

Northland Securities downgraded NxStage Medical (NASDAQ: NXTM) from Outperform to Market Perform with a price target of $12.00 (from $18.00).

For an analyst ratings summary and ratings history on NxStage Medical click here. For more ratings news on NxStage Medical click here.

Shares of NxStage Medical closed at $12.14 yesterday, with a 52 week range of $10.15-$21.87.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
• Baird Downgrades Sonoco Products (SON) to Neutral
• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

Northland Securities

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?